Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals – Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)

Breast care

Thomas Kolben¹  Susanne Maurer¹  Martin Kolben¹  Susanne Engelmann¹ 

[1] aFrauenarztpraxis und Wolfart-Klinik Gräfelfing, München, Germany

关键词: Breast cancer;    Endocrine therapy;    Aromatase inhibitors;   

DOI  :  10.1159/000336531

学科分类：泌尿医学

来源: S Karger AG

【 摘 要 】

Many studies about the adjuvant endocrine therapy of postmenopausal patients with hormone receptor-positive breast cancer have shown significant superiority of aromatase inhibitors (AIs) compared to tamoxifen only. Within these studies, different AIs (anastrozole, letrozole, exemestane) and treatment strategies (upfront, switch, extended adjuvant) were applied.

【 授权许可】

Unknown